文献速递耳科与耳神经

感音神经性听力损失注册临床试验的发表命运及决定因素

Publication Fate and Determinants of Registered Clinical Trials Investigating Sensorineural Hearing Loss.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-08-04

该横断面观察研究评估了ClinicalTrials.gov上250项已完成感音神经性听力损失临床试验的发表比例,发现31.2%已发表。药物试验、报告结果及美国PI与更高或更快的发表几率相关,不同干预类型间存在显著差异。

要点

  • 感音神经性听力损失临床试验发表率为31.2%,低于其他耳鼻咽喉亚专业。
  • 药物试验比器械、行为及其他干预试验发表几率更高且发表速度更快。
  • 报告结果和美国PI所在地与更高的发表几率相关,但发表速度关系不一。

核心结论

  • 感音神经性听力损失相关试验的发表率低于其他耳鼻咽喉亚专业,不同干预类型间存在显著差异,发表方面有较大改进空间以减少发表偏倚。

研究设计与样本

  • 通过ClinicalTrials.gov、PubMed和Google Scholar检索发表状态,采用多变量逻辑回归和生存分析分析发表可能性及发表时间的影响因素。

主要发现

  • 250项已完成试验中31.2%已发表。
  • 多变量逻辑回归显示干预类型、结果可用性和PI所在地是发表的独立预测因素:器械、行为和其他试验的发表几率显著低于药物试验,报告结果增加发表几率,美国PI降低发表几率。
  • Kaplan-Meier和Cox比例风险分析显示药物试验发表速度显著快于器械和其他类别,非美国PI所在地和结果可用性也预测更快的发表。

临床怎么用

  • 临床医生和研究人员应关注感音神经性听力损失试验的发表偏倚,尤其是器械和非药物干预试验。
  • 鼓励报告试验结果并促进非美国PI所在地的试验发表,以提高该领域证据的完整性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the publication proportion of completed clinical trials regarding sensorineural hearing loss (SNHL) registered on ClinicalTrials.gov and identify factors associated with successful and timely publication. STUDY DESIGN: Cross-sectional observational study. SETTING: ClinicalTrials.gov registry and peer-reviewed literature databases. METHODS: We identified completed clinical trials related to SNHL with completion dates before November 1, 2022. Trials were categorized by intervention type, sponsorship, phase, age group, results and location. Publication status was determined by searching ClinicalTrials.gov, PubMed, and Google Scholar. Multivariate logistic regression and survival analysis were used to analyze factors influencing publication likelihood and time-to-publication. RESULTS: Of 250 completed SNHL trials, 31.2% were published. Multivariable logistic regression identified intervention type, results availability, and PI location as independent predictors of publication: device, behavioral, and other trials had significantly lower odds than drug trials, while reported results increased and US-based PI decreased publication odds. Kaplan-Meier and Cox proportional hazards analyses showed drug trials achieved significantly faster publication than device and other categories, with non-US PI location and results availability also predicting faster publication. CONCLUSION: The publication rate of SNHL-related trials is lower than that of other otolaryngology subfields, with significant disparities observed across intervention types. Our findings indicate that there is substantial room for improvement in the publication of sensorineural hearing loss trials to further mitigate publication bias in this field.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Gan H, Chen Z, Xiong H, et al. Publication Fate and Determinants of Registered Clinical Trials Investigating Sensorineural Hearing Loss. Otolaryngol Head Neck Surg. 2026. PMID: 42549865. doi:10.1002/ohn.70354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。